{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T03:46:24Z","timestamp":1765079184198},"reference-count":57,"publisher":"Wiley","issue":"11-12","license":[{"start":{"date-parts":[[2010,9,13]],"date-time":"2010-09-13T00:00:00Z","timestamp":1284336000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:sec><jats:label \/><jats:p><jats:italic>Aliment Pharmacol Ther<\/jats:italic>2010;<jats:bold>32:<\/jats:bold>1332\u20131342<\/jats:p><\/jats:sec><jats:sec><jats:title>Summary<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold>In the UK, oesophagectomy is the current recommendation for patients with persistent high\u2010grade dysplasia in Barrett\u2019s oesophagus. Radiofrequency ablation is an alternative new technology with promising early trial results.<\/jats:p><jats:p><jats:bold>Aim\u2002<\/jats:bold>To undertake a cost\u2013utility analysis comparing these two strategies.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold>We constructed a Markov model to simulate the natural history of a cohort of patients with high\u2010grade dysplasia in Barrett\u2019s oesophagus undergoing one of two treatment options: (i) oesophagectomy or (ii) radiofrequency ablation followed by endoscopic surveillance with oesophagectomy for high\u2010grade dysplasia recurrence or persistence.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold>In the base case analysis, radiofrequency ablation dominated as it generated 0.4 extra quality of life years at a cost saving of \u00a31902. For oesophagectomy to be the most cost\u2010effective option, it required a radiofrequency ablation treatment failure rate (high\u2010grade dysplasia persistence or progression to cancer) of &gt;44%, or an annual risk of high\u2010grade dysplasia recurrence or progression to cancer in the ablated oesophagus of &gt;15% per annum. There was an 85% probability that radiofrequency ablation remained cost\u2010effective at the NICE willingness to pay threshold range of \u00a320\u2003000\u201330\u2003000.<\/jats:p><jats:p><jats:bold>Conclusion\u2002<\/jats:bold>Radiofrequency ablation is likely to be a cost\u2010effective option for high\u2010grade dysplasia in Barrett\u2019s oesophagus in the UK.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1365-2036.2010.04450.x","type":"journal-article","created":{"date-parts":[[2010,9,13]],"date-time":"2010-09-13T06:57:56Z","timestamp":1284361076000},"page":"1332-1342","source":"Crossref","is-referenced-by-count":32,"title":["A UK\u2010based cost\u2013utility analysis of radiofrequency ablation or oesophagectomy for the management of high\u2010grade dysplasia in Barrett\u2019s oesophagus"],"prefix":"10.1111","volume":"32","author":[{"given":"P. C.","family":"Boger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Roderick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,9,13]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1742-1241.1996.tb09543.x","article-title":"Heartburn, oesophagitis and Barrett\u2019s oesophagus in self\u2010medicating patients in general practice","volume":"50","author":"Corder AP","year":"1996","journal-title":"Br J Clin Pract"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1442-2050.2000.00065.x"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.08.053"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1991.03460100089030"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.31599"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.11.018"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(09)70028-2"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2007.07.019"},{"key":"e_1_2_6_10_2","unstructured":"WatsonA HeadingRC ShepherdNA.Guidelines for the diagnosis and management of Barrett\u2019s columnar lined oesophagus. A report of the working party of the British Society of Gastroenterology August 2005. Available at:http:\/\/www.bsg.org.uk\/clinical_guidelines\/oesophageal."},{"key":"e_1_2_6_11_2","volume-title":"The National Oesophago\u2010Gastric Cancer Audit. An audit of the care received by people with Oesophago\u2010gastric Cancer in England and Wales","author":"Palser T","year":"2009"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22833"},{"key":"e_1_2_6_13_2","unstructured":"National Institute for Health and Clinical Excellence.Photodynamic Therapy for Barrett\u2019s Oesophagus: Guidance.National Institute for Health and Clinical Excellence June2010. Available at:http:\/\/www.nice.org.uk\/nicemedia\/live\/11131\/49327\/49327.pdf."},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2006.12.037"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2005.06.047"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0808145"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gassur.2005.12.007"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2168.2000.01470.x"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-4975(02)03496-3"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1067\/msy.2000.103489"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199909000-00015"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1091-255X(99)80056-0"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.02.017"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2004.09.006"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcts.2005.08.018"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1091-255X(02)00153-1"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-007-0330-9"},{"key":"e_1_2_6_28_2","unstructured":"Office of National Statistics.Deaths: age and sex.Health Stat QWinter 2008;40:57table 6.1."},{"key":"e_1_2_6_29_2","unstructured":"NICE Methodology Working Party.Guide to the Methods of Technology Appraisal [Document on the Internet].National Institute for Health and Clinical Excellence June2008. Available at:http:\/\/www.nice.org.uk\/media\/B52\/A7\/TAMethodsGuideUpdatedJune2008.pdf."},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.3310\/hta9050"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-995567"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1067\/mge.2003.327"},{"key":"e_1_2_6_33_2","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198526629.001.0001","volume-title":"Decision Modelling for Health Economic Evaluation","author":"Briggs AH","year":"2006"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-008-0629-1"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2008.142"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2006.03.001"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.3310\/hta10080"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamcollsurg.2005.12.022"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.1800820430"},{"key":"e_1_2_6_40_2","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198529446.001.0001","volume-title":"Methods for the Economic Evaluation of Health Care Programmes","author":"Drummond MF","year":"2005"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6600203"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-4-45"},{"key":"e_1_2_6_43_2","unstructured":"Department of Health.Tariff Information: Confirmation of Payment by Results (PbR) Arrangements for 2009\/10 [Document on the Internet].Department of Health Feb2009. Available at:http:\/\/www.dh.gov.uk\/en\/Publicationsandstatistics\/Publications\/PublicationsPolicyAndGuidance\/DH_094091."},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1002\/hec.985"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1002\/1099-1050(200010)9:7<623::AID-HEC539>3.0.CO;2-V"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.02.062"},{"key":"e_1_2_6_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2007.12.015"},{"key":"e_1_2_6_48_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-995589"},{"key":"e_1_2_6_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(08)61506-1"},{"key":"e_1_2_6_50_2","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.6015"},{"key":"e_1_2_6_51_2","unstructured":"National Institute for Health and Clinical Excellence.Barrett\u2019s Oesophagus \u2013 Ablative Therapy: Full Guideline for Consultation (Draft).National Institute for Health and Clinical Excellence March2010. Available at:http:\/\/www.nice.org.uk\/nicemedia\/live\/12105\/47823\/47823.pdf."},{"key":"e_1_2_6_52_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2003.033837"},{"key":"e_1_2_6_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5107(04)02167-4"},{"key":"e_1_2_6_54_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.25111"},{"key":"e_1_2_6_55_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.52.4.486"},{"key":"e_1_2_6_56_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000184211.75970.85"},{"key":"e_1_2_6_57_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.05.059"},{"key":"e_1_2_6_58_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.316.7126.201"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2010.04450.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2010.04450.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T09:37:46Z","timestamp":1711791466000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2010.04450.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,13]]},"references-count":57,"journal-issue":{"issue":"11-12","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["10.1111\/j.1365-2036.2010.04450.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2010.04450.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,13]]}}}